These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24533867)

  • 1. Validating antimetastatic effects of natural products in an engineered microfluidic platform mimicking tumor microenvironment.
    Niu Y; Bai J; Kamm RD; Wang Y; Wang C
    Mol Pharm; 2014 Jul; 11(7):2022-9. PubMed ID: 24533867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Biomimetic Microfluidic Tumor Microenvironment Platform Mimicking the EPR Effect for Rapid Screening of Drug Delivery Systems.
    Tang Y; Soroush F; Sheffield JB; Wang B; Prabhakarpandian B; Kiani MF
    Sci Rep; 2017 Aug; 7(1):9359. PubMed ID: 28839211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D microfluidic tumor models for biomimetic engineering of glioma niche and detection of cell morphology, migration and phenotype change.
    Lin L; He Z; Jie M; Lin JM; Zhang J
    Talanta; 2021 Nov; 234():122702. PubMed ID: 34364499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-Scale Antitumor Screening Based on Heterotypic 3D Tumors Using an Integrated Microfluidic Platform.
    Liu W; Sun M; Han K; Wang J
    Anal Chem; 2019 Nov; 91(21):13601-13610. PubMed ID: 31525029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bladder cancer microenvironment simulation system based on a microfluidic co-culture model.
    Liu PF; Cao YW; Zhang SD; Zhao Y; Liu XG; Shi HQ; Hu KY; Zhu GQ; Ma B; Niu HT
    Oncotarget; 2015 Nov; 6(35):37695-705. PubMed ID: 26462177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomimetic microfluidic device for in vitro antihypertensive drug evaluation.
    Li L; Lv X; Ostrovidov S; Shi X; Zhang N; Liu J
    Mol Pharm; 2014 Jul; 11(7):2009-15. PubMed ID: 24673554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro biomimetic models for glioblastoma-a promising tool for drug response studies.
    Stanković T; Ranđelović T; Dragoj M; Stojković Burić S; Fernández L; Ochoa I; Pérez-García VM; Pešić M
    Drug Resist Updat; 2021 Mar; 55():100753. PubMed ID: 33667959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascularized microfluidic platforms to mimic the tumor microenvironment.
    Michna R; Gadde M; Ozkan A; DeWitt M; Rylander M
    Biotechnol Bioeng; 2018 Nov; 115(11):2793-2806. PubMed ID: 29940072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro throughput screening of anticancer drugs using patient-derived cell lines cultured on vascularized three-dimensional stromal tissues.
    Takahashi Y; Morimura R; Tsukamoto K; Gomi S; Yamada A; Mizukami M; Naito Y; Irie S; Nagayama S; Shinozaki E; Yamaguchi K; Fujita N; Kitano S; Katayama R; Matsusaki M
    Acta Biomater; 2024 Jul; 183():111-129. PubMed ID: 38801868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Targeting of Tumor Cells in a Microfluidic Tumor Model with Multiple Cell Types.
    van de Crommert B; Palacio-Castañeda V; Verdurmen WPR
    Methods Mol Biol; 2024; 2804():237-251. PubMed ID: 38753152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput screening approaches and combinatorial development of biomaterials using microfluidics.
    Barata D; van Blitterswijk C; Habibovic P
    Acta Biomater; 2016 Apr; 34():1-20. PubMed ID: 26361719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three dimensional microfluidic cell arrays for ex vivo drug screening with mimicked vascular flow.
    Dereli-Korkut Z; Akaydin HD; Ahmed AH; Jiang X; Wang S
    Anal Chem; 2014 Mar; 86(6):2997-3004. PubMed ID: 24568664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine.
    Yang J; Fang Z; Wu J; Yin X; Fang Y; Zhao F; Zhu S; Li Y
    Tumour Biol; 2016 Oct; 37(10):13871-13883. PubMed ID: 27485114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of drugs as single agents or in combination to prevent carcinoma dissemination in a microfluidic 3D environment.
    Bai J; Tu TY; Kim C; Thiery JP; Kamm RD
    Oncotarget; 2015 Nov; 6(34):36603-14. PubMed ID: 26474384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiwell capillarity-based microfluidic device for the study of 3D tumour tissue-2D endothelium interactions and drug screening in co-culture models.
    Virumbrales-Muñoz M; Ayuso JM; Olave M; Monge R; de Miguel D; Martínez-Lostao L; Le Gac S; Doblare M; Ochoa I; Fernandez LJ
    Sci Rep; 2017 Sep; 7(1):11998. PubMed ID: 28931839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug Discovery.
    Agarwal P; Wang H; Sun M; Xu J; Zhao S; Liu Z; Gooch KJ; Zhao Y; Lu X; He X
    ACS Nano; 2017 Jul; 11(7):6691-6702. PubMed ID: 28614653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Microvascularized Tumor-mimetic Platform for Assessing Anti-cancer Drug Efficacy.
    Pradhan S; Smith AM; Garson CJ; Hassani I; Seeto WJ; Pant K; Arnold RD; Prabhakarpandian B; Lipke EA
    Sci Rep; 2018 Feb; 8(1):3171. PubMed ID: 29453454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microfluidic co-culture of liver tumor spheroids with stellate cells for the investigation of drug resistance and intercellular interactions.
    Chen Y; Sun W; Kang L; Wang Y; Zhang M; Zhang H; Hu P
    Analyst; 2019 Jul; 144(14):4233-4240. PubMed ID: 31210202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microfluidic modelling of the tumor microenvironment for anti-cancer drug development.
    Shang M; Soon RH; Lim CT; Khoo BL; Han J
    Lab Chip; 2019 Jan; 19(3):369-386. PubMed ID: 30644496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal Adenocarcinoma Cell Culture in a Microfluidically Controlled Environment with a Static Molecular Gradient of Polyphenol.
    Szafran RG; Gąsiorowski K; Wiatrak B
    Molecules; 2021 May; 26(11):. PubMed ID: 34072020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.